Corient Private Wealth’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
24,905
+399
+2% +$14.4K ﹤0.01% 1725
2026
Q1
$601K Buy
+24,506
New +$580K ﹤0.01% 1935

Other funds holding ASTH

Corient Private Wealth's ASTH Position: Q2 2026 in Review

Corient Private Wealth increased its Astrana Health (ASTH) stake by 1.6% in Q2 2026, buying an estimated $14.4K and bringing the position to 24,905 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1725.

Corient Private Wealth first reported a position in ASTH in Q1 2026 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Corient Private Wealth held 24,905 shares of Astrana Health worth $1.16M as of Q2 2026.
  • Corient Private Wealth bought 399 Astrana Health shares in Q2 2026, an estimated $14.4K.
  • Astrana Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1725 holding.
  • Corient Private Wealth first reported a position in Astrana Health in Q1 2026 and has held it in 2 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.